AQST Annual D&A
$1.34 M
-$1.04 M-43.65%
31 December 2023
Summary:
As of January 22, 2025, AQST annual depreciation & amortization is $1.34 million, with the most recent change of -$1.04 million (-43.65%) on December 31, 2023. During the last 3 years, it has fallen by -$2.10 million (-60.94%). AQST annual D&A is now -65.43% below its all-time high of $3.89 million, reached on December 31, 2016.AQST Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AQST Quarterly D&A
$159.00 K
-$46.00 K-22.44%
30 September 2024
Summary:
As of January 22, 2025, AQST quarterly depreciation & amortization is $159.00 thousand, with the most recent change of -$46.00 thousand (-22.44%) on September 30, 2024. Over the past year, it has dropped by -$104.00 thousand (-39.54%). AQST quarterly D&A is now -85.62% below its all-time high of $1.11 million, reached on December 31, 2020.AQST Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AQST TTM D&A
$1.04 M
-$104.00 K-9.10%
30 September 2024
Summary:
As of January 22, 2025, AQST TTM depreciation & amortization is $1.04 million, with the most recent change of -$104.00 thousand (-9.10%) on September 30, 2024. Over the past year, it has dropped by -$235.00 thousand (-18.45%). AQST TTM D&A is now -72.84% below its all-time high of $3.83 million, reached on March 31, 2018.AQST TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AQST Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.6% | -39.5% | -18.4% |
| 3 y3 years | -60.9% | -39.5% | -18.4% |
| 5 y5 years | -58.4% | -39.5% | -18.4% |
AQST Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -78.3% | at low | -65.0% | at low |
| 5 y | 5-year | -60.9% | at low | -85.6% | at low | -69.8% | at low |
| alltime | all time | -65.4% | at low | -85.6% | at low | -72.8% | +12.0% |
Aquestive Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $159.00 K(-22.4%) | $1.04 M(-9.1%) |
| June 2024 | - | $205.00 K(-1.0%) | $1.14 M(-6.8%) |
| Mar 2024 | - | $207.00 K(-55.8%) | $1.23 M(-8.8%) |
| Dec 2023 | $1.34 M(-43.7%) | $468.00 K(+77.9%) | $1.34 M(+5.6%) |
| Sept 2023 | - | $263.00 K(-9.0%) | $1.27 M(-20.7%) |
| June 2023 | - | $289.00 K(-11.1%) | $1.61 M(-19.0%) |
| Mar 2023 | - | $325.00 K(-18.1%) | $1.99 M(-16.8%) |
| Dec 2022 | $2.39 M(-19.5%) | $397.00 K(-33.4%) | $2.39 M(-12.3%) |
| Sept 2022 | - | $596.00 K(-10.6%) | $2.72 M(-4.9%) |
| June 2022 | - | $667.00 K(-8.3%) | $2.86 M(-2.6%) |
| Mar 2022 | - | $727.00 K(-0.5%) | $2.94 M(-0.9%) |
| Dec 2021 | $2.96 M(-13.9%) | $731.00 K(-0.7%) | $2.96 M(-11.2%) |
| Sept 2021 | - | $736.00 K(-0.8%) | $3.34 M(+2.5%) |
| June 2021 | - | $742.00 K(-1.7%) | $3.26 M(-1.7%) |
| Mar 2021 | - | $755.00 K(-31.7%) | $3.31 M(-3.8%) |
| Dec 2020 | $3.44 M | $1.11 M(+69.4%) | $3.44 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $653.00 K(-18.1%) | $2.95 M(-3.0%) |
| June 2020 | - | $797.00 K(-10.1%) | $3.05 M(+1.2%) |
| Mar 2020 | - | $887.00 K(+43.8%) | $3.01 M(+3.6%) |
| Dec 2019 | $2.90 M(-10.2%) | $617.00 K(-17.2%) | $2.90 M(-4.7%) |
| Sept 2019 | - | $745.00 K(-2.0%) | $3.05 M(-0.0%) |
| June 2019 | - | $760.00 K(-2.9%) | $3.05 M(-0.6%) |
| Mar 2019 | - | $783.00 K(+3.0%) | $3.07 M(-5.3%) |
| Dec 2018 | $3.24 M(-14.9%) | $760.00 K(+1.9%) | $3.24 M(-6.0%) |
| Sept 2018 | - | $746.00 K(-4.0%) | $3.44 M(-5.8%) |
| June 2018 | - | $777.00 K(-18.5%) | $3.65 M(-4.5%) |
| Mar 2018 | - | $953.00 K(-1.4%) | $3.83 M(+0.7%) |
| Dec 2017 | $3.80 M(-2.3%) | $967.00 K(+1.0%) | $3.80 M(+34.1%) |
| Sept 2017 | - | $957.00 K(+0.8%) | $2.83 M(+51.0%) |
| June 2017 | - | $949.00 K(+2.3%) | $1.88 M(+102.3%) |
| Mar 2017 | - | $928.00 K | $928.00 K |
| Dec 2016 | $3.89 M | - | - |
FAQ
- What is Aquestive Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual D&A year-on-year change?
- What is Aquestive Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly D&A year-on-year change?
- What is Aquestive Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aquestive Therapeutics?
- What is Aquestive Therapeutics TTM D&A year-on-year change?
What is Aquestive Therapeutics annual depreciation & amortization?
The current annual D&A of AQST is $1.34 M
What is the all time high annual D&A for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual depreciation & amortization is $3.89 M
What is Aquestive Therapeutics annual D&A year-on-year change?
Over the past year, AQST annual depreciation & amortization has changed by -$1.04 M (-43.65%)
What is Aquestive Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AQST is $159.00 K
What is the all time high quarterly D&A for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly depreciation & amortization is $1.11 M
What is Aquestive Therapeutics quarterly D&A year-on-year change?
Over the past year, AQST quarterly depreciation & amortization has changed by -$104.00 K (-39.54%)
What is Aquestive Therapeutics TTM depreciation & amortization?
The current TTM D&A of AQST is $1.04 M
What is the all time high TTM D&A for Aquestive Therapeutics?
Aquestive Therapeutics all-time high TTM depreciation & amortization is $3.83 M
What is Aquestive Therapeutics TTM D&A year-on-year change?
Over the past year, AQST TTM depreciation & amortization has changed by -$235.00 K (-18.45%)